Item Type | Name |
Academic Article
|
Phase I study of recombinant human endostatin in patients with advanced solid tumors.
|
Academic Article
|
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
|
Academic Article
|
The development and characterization of a human midgut carcinoid cell line.
|
Academic Article
|
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells.
|
Academic Article
|
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
|
Academic Article
|
Effect of molecular therapeutics on liver regeneration in a murine model.
|
Academic Article
|
Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
|
Concept
|
Vascular Endothelial Growth Factor C
|
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
Concept
|
Vascular Endothelial Growth Factor B
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
Academic Article
|
Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.
|
Academic Article
|
A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
|
Academic Article
|
Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
|
Academic Article
|
Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.
|
Academic Article
|
Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1beta.
|
Academic Article
|
The vascular endothelial growth factor family and its receptors.
|
Academic Article
|
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
|
Academic Article
|
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
|
Academic Article
|
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
|
Academic Article
|
Bevacizumab beyond progression: does this make sense?
|
Academic Article
|
Predictive biomarkers for bevacizumab: are we there yet?
|
Academic Article
|
Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.
|
Academic Article
|
Role of angiogenesis in the development and growth of liver metastasis.
|
Academic Article
|
Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors.
|
Academic Article
|
Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer.
|
Academic Article
|
Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells.
|
Academic Article
|
Regulators of vascular endothelial growth factor expression in cancer.
|
Academic Article
|
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
|
Academic Article
|
Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
|
Academic Article
|
Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
|
Academic Article
|
Bevacizumab.
|
Academic Article
|
Vascular endothelial growth factor receptors: expression and function in solid tumors.
|
Academic Article
|
Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
|
Academic Article
|
Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
|
Academic Article
|
Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected.
|
Academic Article
|
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
|
Academic Article
|
Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer.
|
Academic Article
|
Antiangiogenic therapy targeting factors that enhance endothelial cell survival.
|
Academic Article
|
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.
|
Academic Article
|
Biology of angiogenesis in tumors of the gastrointestinal tract.
|
Academic Article
|
Promises and pitfalls of anti-angiogenic therapy in clinical trials.
|
Academic Article
|
Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
|
Academic Article
|
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
|
Academic Article
|
Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?
|
Academic Article
|
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
|
Academic Article
|
Angiogenesis and its role in colorectal tumor and metastasis formation.
|
Academic Article
|
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
|
Academic Article
|
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
|
Academic Article
|
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
|
Academic Article
|
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
|
Academic Article
|
VEGF-targeted therapy: mechanisms of anti-tumour activity.
|
Academic Article
|
Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.
|
Academic Article
|
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.
|
Academic Article
|
Targeting tumor angiogenesis.
|
Academic Article
|
Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
|
Academic Article
|
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.
|
Academic Article
|
The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion.
|
Academic Article
|
Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
|
Academic Article
|
Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma.
|
Academic Article
|
ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.
|
Academic Article
|
Preclinical data targeting vascular endothelial growth factor in colorectal cancer.
|
Academic Article
|
Current overview of angiogenesis inhibitors.
|
Academic Article
|
Functional significance of VEGFR-2 on ovarian cancer cells.
|
Academic Article
|
Cancer: The nuances of therapy.
|
Academic Article
|
Is there really a yin and yang to VEGF-targeted therapies?
|
Academic Article
|
Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
|
Academic Article
|
Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer.
|
Academic Article
|
Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
|
Academic Article
|
Overview of anti-VEGF therapy and angiogenesis. Part 1: Angiogenesis inhibition in solid tumor malignancies.
|
Academic Article
|
Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer.
|
Academic Article
|
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic.
|
Academic Article
|
VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells.
|
Academic Article
|
Intracrine VEGF signaling mediates the activity of prosurvival pathways in human colorectal cancer cells
|
Academic Article
|
The role of vascular endothelial growth factor in renal cancer progression
|
Academic Article
|
Expression of Vascular Endothelial Growth Factor and Its Receptor, KDR, Correlates with Vascularity, Metastasis, and Proliferation of Human Colon Cancer
|
Academic Article
|
Anti-vascular endothelial growth factor therapy
|
Academic Article
|
Mechanisms of action of anti-VEGF therapy
|
Academic Article
|
Inhibition of vascular endothelial growth factor receptor-1/Wnt/ β-catenin crosstalk leads to tumor cell death
|
Academic Article
|
Inhibition of Vascular Endothelial Growth Factor Receptor-1/Wnt/{beta}-catenin Crosstalk Leads to Tumor Cell Death.
|
Academic Article
|
Antiangiogenic therapy in oncology: current status and future directions.
|
Academic Article
|
Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells.
|
Academic Article
|
Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion.
|
Academic Article
|
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.
|